Product Detail
|
|||||||||
Similar Items
- Colombo's Tips and Tricks for Drug Eluting Stents by Antonio Colombo
- Handbook of Drug-Eluting Stents by Patrick Serruys
- Dx/Rx: Congestive Heart Failure by Theo Meyer
- Strategic Approaches in Coronary Intervention by Stephen G. Ellis
- Clinical, Interventional and Investigational Thrombocardiology by Richard Becker
- Practical Intracardiac Echocardiography in Electrophysiology by Jian-Fang Ren
- Advanced ECG: Boards and Beyond by Brendan Phibbs
- Primary Angioplasty by David Antoniucci
| Customer Reviews |
| Be the first to review this product |
Browse Titles In Related Subjects
Additional Description
Contributors ix
Preface x
Acknowledgments xi
Part I Background 1 (30)
1 Introduction and overview
3 (4)
Christopher J White
2 Mechanisms of restenosis following percutaneous coronary interventions
7 (12)
Salman A Arain and John P Reilly
3 Drug-eluting stent platforms: antiproliferative drugs and polymer coatings
19 (12)
Albert W Chan
Part II Treatment of Restenosis 31 (36)
4 Trials of oral drug therapy to reduce restenosis
33 (8)
Jose A Silva
5 Non-stent devices to reduce restenosis
41 (16)
Srinivasa P Potluri and Jose A Silva
6 Clinical trials of bare metal stents to reduce restenosis
57 (10)
Jose A Silva
Part III Clinical Experience with Drug-Eluting Stents 67 (38)
7 Clinical trials: bare metal stents versus drug-eluting stents
69 (12)
Ali F Aboufares and Stephen R Ramee
8 Broader indications (off-label use) for coronary drug-eluting stents
81 (14)
Albert W Chan
9 Complications related to drug-eluting stents
95 (10)
Jose A Silva
Part IV Optimal Patient Management and Selection for Drug-Eluting Stents 105 (30)
10 Patient selection criteria for drug-eluting stents
107 (8)
Ali Morshedi-Meibodi and J Stephen Jenkins
11 Optimal antiplatelet and anticoagulation therapy for drug-eluting stents
115 (10)
Mahesh S Mulumudi and Tyrone J Collins
12 Optimal deployment strategies for drug-eluting stents
125 (10)
Georges A Feghali and Bahji N Khuri
Part V Cost-Benefit Analysis and Future Strategies for Drug-Eluting Stents 135 (14)
13 Cost analysis for coronary drug-eluting stents
137 (8)
John P Reilly
14 The future of drug-eluting stents
145 (4)
Christopher J White
Index 149


